Here is what the page “MIT's Customizable Nanoparticles Could Deliver Personalized Cancer Vaccines | Nova Global ” contains. Researchers at MIT have engineered a nanoscale particle that could serve as a customizable delivery vehicle for personalized cancer vaccines. The particle is based on a modified, harmless bacteriophage called M13, which forms a nanofiber that can be coated with cancer antigens. MIT's Customizable Nanoparticles Could Deliver Personalized Cancer Vaccines
By precisely controlling the density of these cancer proteins on the nanofiber, the team was able to create a vaccine that prevented the development of colon tumors in mice. This breakthrough, published in a recent study, demonstrates the potential of using engineered viral nanoparticles to stimulate a strong immune response against cancer. The M13 bacteriophage is an ideal scaffold because it is safe in humans and can be easily modified to display different antigens. For the complete material, the listing points back to the source inside the network.